Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (ARROW): interim analysis results of a randomised, phase 3 study

DSpace Repository

Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (ARROW): interim analysis results of a randomised, phase 3 study

Author: Moreau, Philippe; Mateos, Maria-Victoria; Berenson, James R.; Weisel, Katja; Lazzaro, Antonio; Song, Kevin; Dimopoulos, Meletios A.; Huang, Mei; Zahlten-Kumeli, Anita; Stewart, A. Keith
Tübinger Autor(en):
Weisel, Katja
Published in: Lancet Oncology (2018), Bd. 19, H. 7, S. 953-964
Verlagsangabe: Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S1470-2045(18)30354-1
ISSN: 1474-5488
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)